Abstract
Each of the roughly 100 types of human cancer is caused by the activation of proto-oncogenes and the loss of tumor suppressor genes. Although cancer genomes are complex, some clear mutational patterns are apparent. Several cancer genes are observed very frequently in some types of cancer, but rarely found in other types. Other cancer genes are much more widespread across many types of cancer. Analysis of many cancer genomes has shown that nearly 150 genes are recurrently altered by mutations to provide tumor cells a selective growth advantage. These studies have shown that there are many potential combinations of cancer genes that can cooperatively allow the growth of different types of neoplasia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Agrawal N et al (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154–1157
Ahn SM et al (2014) Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology 60:1972–1982
Brennan CW et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477
Cancer Genome Atlas Research Network (2012a) Comprehensive molecular portraits of human breast tumors. Nature 490:61–70
Cancer Genome Atlas Research Network (2012b) Integrated genomic analyses of ovarian carcinoma. Nature 474:609–615
Cancer Genome Atlas Research Network (2013a) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368:2059–2074
Cancer Genome Atlas Research Network (2013b) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:43–49
Cancer Genome Atlas Research Network (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543–550
de Snoo FA, Hayward NK (2005) Cutaneous melanoma susceptibility and progression genes. Cancer Lett 230:153–186
Ellenson LH, Wu TC (2004) Focus on endometrial and cervical cancer. Cancer Cell 5:533–538
El-Rifai W, Powell SM (2002) Molecular biology of gastric cancer. Semin Radiat Oncol 12:128–140
Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674–687
Gao JJ et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:l1
Grasso CS et al (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487:239–243
Haluska FG et al (2006) Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12:2301s–2307s
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166–2176
Iyer G et al (2013) Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. J Clin Oncol 31:3133–3140
Jones S et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806
Kangelaris KN, Gruber SB (2007) Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer. JAMA 297:2410–2411
Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292–306
Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163–2172
Munger K et al (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78:11451–11460
Northcott PA et al (2011) Medulloblastoma comprises four distinct molecular variants. JCO 29:1408–1414
Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445–1453
Rudin CM et al (2012) Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 44:1111–1116
Seshagiri S et al (2012) Recurrent R-spondin fusions in colon cancer. Nature 488:660–664
Sjoblom T et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274
Wang K et al (2014) Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 46:573–582
Warnakulasuriya KA, Ralhan R (2007) Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco – a review. J Oral Pathol Med 36:63–77
Wood LD et al (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108–1113
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Bunz, F. (2016). Genetic Alternations in Common Cancers. In: Principles of Cancer Genetics. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7484-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-017-7484-0_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7482-6
Online ISBN: 978-94-017-7484-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)